MDS.UN — Healthcare Special Opportunities Fund Income Statement
0.000.00%
- CA$16.11m
- CA$16.03m
- CA$2.99m
- 88
- 82
- 50
- 86
Annual income statement for Healthcare Special Opportunities Fund, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.49 | 2.01 | -4.69 | 0.981 | 2.99 |
Cost of Revenue | |||||
Gross Profit | 1.92 | 1.42 | -5.21 | 0.602 | 2.59 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.616 | 0.721 | 0.665 | 0.521 | 0.546 |
Operating Profit | 1.88 | 1.29 | -5.35 | 0.461 | 2.44 |
Net Income Before Taxes | 1.88 | 1.29 | -5.35 | 0.461 | 2.44 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.83 | 1.25 | -5.37 | 0.437 | 2.42 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.83 | 1.25 | -5.37 | 0.437 | 2.42 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.83 | 1.25 | -5.37 | 0.437 | 2.42 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.683 | 0.475 | -2.22 | 0.273 | 1.64 |
Dividends per Share | |||||
Special Dividends per Share |